The Drugs Controller General of India has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila......
If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini......
Union health ministry officials on Thursday clarified that the intent of the Indian Council of Medical Research director general's letter envisaging the launch of COVID-19 vaccine by August 15 was......
India's apex medical body Indian Council of Medical Research said on Friday that it aims to launch the world's first COVID-19 vaccine, the indigenously developed Covaxin, by August 15, and has......
Human clinical trials for a vaccine for COVID-19 has been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed......
Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug......
Investors turn their attention to export-driven sectors, experts tell Krishna Kant. Illustration: Uttam Ghosh After betting on the domestic consumption story for over three years, equity investors......
Markets scaled higher on the last day of December derivatives series due to strength in energy and index heavyweight shares such as HDFC and Infosys. The S&P BSE Sensex ended higher 158 points at......
The S&P BSE Sensex closed at 26,190, up by 43 points and Nifty50 settled above 7,950 to end at 7,963, up by 17 points Markets ended the first day of the New Year on a tentative note as selling......
Markets ended lower on Wednesday, amid weak European cues, on profit taking after sharp gains in the previous two sessions which lifted the benchmark share indices to their record highs. Meanwhile,......